ARIAD Pharmaceuticals
defunct oncology company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 15 annual filings
Revenue
$283.06M
Net Income
$287.20M
Assets
$751.59M
EPS (diluted)
$2.07
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001600620-26-000017ARIAD Pharmaceuticals
Summary
ARIAD Pharmaceuticals is a business[1].
Key Facts
- ARIAD Pharmaceuticals is in the country of United States[2].
- ARIAD Pharmaceuticals is in the country of US[3].
- ARIAD Pharmaceuticals's instance of is recorded as business[4].
- ARIAD Pharmaceuticals's instance of is recorded as public company[5].
- ARIAD Pharmaceuticals's founder is recorded as Harvey Berger[6].
- ARIAD Pharmaceuticals is owned by Takeda Pharmaceutical Company[7].
- ARIAD Pharmaceuticals's headquarters location is recorded as Cambridge[8].
- ARIAD Pharmaceuticals's child organization or unit is recorded as ARIAD Pharmaceuticals (United Kingdom)[9].
- ARIAD Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
- 1991 marks the founding of ARIAD Pharmaceuticals[11].
- ARIAD Pharmaceuticals's official website is recorded as http://www.ariad.com/[12].
- ARIAD Pharmaceuticals's product or material produced is recorded as ponatinib[13].
- ARIAD Pharmaceuticals's legal form is recorded as Delaware corporation[14].
- ARIAD Pharmaceuticals's legal form is recorded as XTIQ[15].
Body
Founding
ARIAD Pharmaceuticals's founder is recorded as Harvey Berger[6]. 1991 marks the founding of it[11].
Operations
ARIAD Pharmaceuticals's headquarters location is recorded as Cambridge[8]. Its child organization or unit is recorded as it (United Kingdom)[9].
Industry
ARIAD Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
Ownership
ARIAD Pharmaceuticals is owned by Takeda Pharmaceutical Company[7]. Its product or material produced is recorded as ponatinib[13].